Noticias de OVID_US

Noticias del mercado

Últimas noticias sobre OVID_US — 115 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: OVID_US ✕ 115 resultados
20/04/2026 OVID_US — Investing.com
H.C. Wainwright reiterates Ovid Therapeutics stock rating at buy
20/04/2026 OVID_US — TradingView
Ovid Therapeutics sees $53.9M gross proceeds as Series A warrants mostly exercised
20/04/2026 OVID_US — TipRanks
Ovid Therapeutics Boosts Capital Through Warrant Exercises
20/04/2026 OVID_US — Stock Titan
Warrant exercises bring Ovid Therapeutics (NASDAQ: OVID) $53.9M cash
20/04/2026 OVID_US — Investing.com
Ovid Therapeutics receives $53.9 million from warrant exercises
15/04/2026 OVID_US — Intellectia AI ES ← EN
Noticias de acciones de OVID.O hoy | Ganancias, eventos y alertas de precios
15/04/2026 OVID_US — GuruFocus ES ← EN
OVID reiterado por Wedbush: el precio objetivo se mantiene en 7,00 dólares
15/04/2026 OVID_US — Investing.com India
Leerink reiterates Ovid Therapeutics stock rating on KCC2 potential By Investing.com
15/04/2026 OVID_US — Investing.com
Leerink reiterates Ovid Therapeutics stock rating on KCC2 potential By Investing.com
15/04/2026 OVID_US — Investing.com
Leerink reiterates Ovid Therapeutics stock rating on KCC2 potential By Investing.com
15/04/2026 OVID_US — Seeking Alpha
Ovid Therapeutics Inc. (OVID) Discusses KCC2 Deep Dive and Pipeline Advances in CNS Disorders - Slideshow
15/04/2026 OVID_US — Investing.com
Leerink reiterates Ovid Therapeutics stock rating on KCC2 potential
09/04/2026 OVID_US — Investing.com
H.C. Wainwright raises Ovid Therapeutics stock price target to $4 By Investing.com
09/04/2026 OVID_US — Investing.com
H.C. Wainwright raises Ovid Therapeutics stock price target to $4
09/04/2026 OVID_US — GuruFocus
Ovid Therapeutics (OVID): HC Wainwright & Co. Raises Price Targe
09/04/2026 OVID_US — timothysykes.com
Ovid Therapeutics Surge: Positive Phase 1 Data Ignites Market Confidence
09/04/2026 OVID_US — Investing.com UK
H.C. Wainwright raises Ovid Therapeutics stock price target to $4 By Investing.com
09/04/2026 OVID_US — Stock Titan
[Form 4] Ovid Therapeutics Inc. Insider Trading Activity
09/04/2026 OVID_US — Stock Titan
Director Kevin Fitzgerald awarded Ovid Therapeutics (OVID) RSU compensation
09/04/2026 OVID_US — Stock Titan
Ovid Therapeutics (NASDAQ: OVID) director granted RSUs in lieu of cash pay

Página 3 de 6

keyboard_arrow_up